Study Reveals Rapid Prescriptions of ADHD Medication to Preschoolers Are Common and Often Contradict Guidelines
Many preschoolers diagnosed with ADHD are prescribed medication immediately, often contrary to treatment guidelines that recommend behavioral therapy first. A recent study underscores the need for better adherence to recommended practices and improved access to behavioral interventions.
Recent research led by Stanford Medicine highlights a concerning trend in the treatment of young children diagnosed with Attention Deficit/Hyperactivity Disorder (ADHD). The study found that many preschoolers are being prescribed ADHD medications immediately following diagnosis, which conflicts with the treatment guidelines set by the American Academy of Pediatrics. According to the guidelines, children aged 4 and 5 should typically undergo at least six months of behavioral therapy before considering medication.
The investigation analyzed electronic health records from nearly 10,000 children across various U.S. pediatric care networks between 2016 and 2023. Results indicated that over 42% of children diagnosed with ADHD received medication within the first month, with only a small percentage (14.1%) starting medication after six months, as recommended. The study suggests that this rapid prescription pattern may be driven by systemic barriers, such as limited access to behavioral therapy options and insurance coverage issues, prompting doctors to opt for medication as a quicker solution.
The study's lead author, Dr. Yair Bannett, emphasized the importance of behavioral interventions, which can include parent training in behavior management to help children develop coping skills and routines. While medications can help alleviate symptoms like hyperactivity and inattentiveness, they can also cause side effects, especially in very young children whose bodies metabolize drugs differently.
Bannett pointed out that early effective treatment, combining behavioral strategies and medication when appropriate, can significantly improve academic outcomes and long-term life skills. He advocates for better access to behavioral therapy resources and increased awareness among pediatricians to ensure that treatment adheres to established guidelines, ultimately offering the best support for these young children.
Source: https://medicalxpress.com/news/2025-08-adhd-drugs-quickly-preschoolers.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Evolocumab Shows No Benefit in Preventing Vein Graft Disease After Coronary Bypass Surgery, Major Trial Finds
A recent trial reveals that evolocumab, despite significantly lowering LDL cholesterol, does not reduce vein graft disease rates after coronary artery bypass surgery, pointing to the need for novel treatment strategies.
Recovery in Colorado: Older Adults Near Pre-Pandemic Death Rates, While Middle-Aged Show Increased Risks
Older Coloradans are nearly back to pre-pandemic death rates, but middle-aged adults face continued increased risks, mainly from overdoses, highlighting ongoing public health challenges. Explore the latest insights in this comprehensive overview.
How CAR-T Cell Therapy Is Transforming Cancer Treatment
Discover how CAR-T cell therapy is transforming cancer treatment by harnessing genetically engineered immune cells to target and destroy tumors with unprecedented precision and strength.
Fentanyl Alone Responsible for Majority of Youth Overdose Deaths from 2018 to 2022, Study Finds
A new study highlights that fentanyl alone was responsible for the majority of youth overdose deaths between 2018 and 2022, with a 168% increase over five years. Public health strategies must adapt to these evolving risks.